Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05001880
Title Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

peritoneal mesothelioma

Therapies

Bevacizumab + Carboplatin + Pemetrexed Disodium

Atezolizumab + Bevacizumab + Carboplatin + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.